Physician profile
Jay S Badell
NPI 1679035034
$44,832.57
in general payments reported to CMS, 2019-2025
31 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.03 · 2020: $153 · 2021: $2,625 · 2022: $3,067 · 2023: $3,420 · 2024: $7,315 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $5,779 · Food and Beverage: $4,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,450.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,350.00 |
| Travel and Lodging | $5,779.05 |
| Food and Beverage | $4,379.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $18,456.68 | 2023-2025 | Biobrace 23mm, Hercules Suture Anchor System, Colink 2 |
| Alafair Biosciences, INC. | $13,615.06 | 2024-2025 | Versawrap |
| Crossroads Orthopedics, LLC | $3,629.00 | 2021-2022 | |
| Flower Orthopedics Coporation | $2,017.43 | 2023-2025 | |
| Vilex LLC | $1,982.95 | 2023 | |
| Arthrex, INC. | $1,427.43 | 2022-2024 | Arthrex |
| Extremity Medical | $679.83 | 2024 | Omni Mini |
| Smith+Nephew, INC. | $633.95 | 2020-2024 | Q-Fix, Grafix Pl, Novostitch |
| Stryker Corporation | $411.68 | 2023-2025 | Inbone, Easyfuse, Augment Injectable |
| Triad Life Sciences INC. | $232.22 | 2022 | |
| Ossio INC | $179.04 | 2024 | |
| Medline Industries LP | $172.40 | 2024 | |
| Coastal Medical Technologies LLC | $159.29 | 2023-2024 | |
| Acera Surgical, INC. | $139.79 | 2024 | Restrata Wound Matrix |
| Convatec INC. | $136.57 | 2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $124.99 | 2022 | |
| Nevro Corp. | $124.71 | 2023 | Senza |
| Theramicro, INC. | $122.18 | 2025 | Allostat Gfx, Tekbrace Solo |
| Organogenesis INC. | $119.06 | 2023 | Puraply |
| Orthofix Medical, INC. | $111.95 | 2023 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $104.40 | 2022 | |
| Depuy Synthes Sales INC. | $84.64 | 2024-2025 | Healix Knotless Peek, Motoband |
| Horizon Therapeutics Plc | $29.03 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.94 | 2025 | |
| Mvp Orthopedics INC | $20.08 | 2022 | |
| Paragon 28, INC. | $18.50 | 2025 | R3flex |
| Solventum Corporation | $18.18 | 2025 | Prevena |
| Heron Therapeutics, INC. | $17.76 | 2023 | Zynrelef |
| Arteriocyte Medical Systems, INC. | $17.70 | 2022 | |
| Kci USA, INC. | $12.75 | 2022 | |
| Biocomposites INC | $9.38 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Badell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.